Atlanpole Biotherapies will be exhibiting at Bio 2010 in Chicago from 3-6 May, allowing access to extended skills from biodiagnostic to biomedicine.
Atlanpole Biotherapies is a cluster that draws together a community of innovative companies, fundamental and clinical research organisations and higher-education institutions, all located in western France.
Its stakeholders offer comprehensive solutions along the entire biotherapeutic value chain, from discovery to patient, within four areas of excellence: immunobiotherapies, radiopharmaceutical, cell and gene therapies and biomaterials.
